Clinical Trial Update: T and B Cell Responses in Autoimmune Diseases

View source ↗

Summary

A clinical trial evaluating T and B cell responses in autoimmune diseases has been terminated. The update notes the study status and participating conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Multiple Sclerosis
• Psoriasis
• Rheumatoid Arthritis
• Type 1 Diabetes Mellitus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus, Multiple Sclerosis | Status: TERMINATED